Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword

17Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have recently shown that Toll-like receptor (TLR) signaling exacerbates pancreatic fibro-inflammation and promotes carcinogenesis in mice. Paradoxically, inhibition of the TLR-MYD88 signaling pathway is pro-tumorigenic owing to the dendritic cell-mediated TH2-polarization of CD4+ T cells. TLR signaling appears to be central in pancreatic cancerassociated inflammation. © 2013 Landes Bioscience.

Cite

CITATION STYLE

APA

Zambirinis, C. P., & Miller, G. (2013). Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword. OncoImmunology, 2(1). https://doi.org/10.4161/onci.22567

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free